A detailed history of Cibc World Market Inc. transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Cibc World Market Inc. holds 41,200 shares of IPA stock, worth $14,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,200
Previous 41,200 -0.0%
Holding current value
$14,008
Previous $42,000 38.1%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$1.11 - $2.3 $555 - $1,150
-500 Reduced 1.2%
41,200 $70,000
Q3 2023

Nov 13, 2023

SELL
$1.76 - $3.04 $1,279 - $2,210
-727 Reduced 1.71%
41,700 $76,000
Q1 2023

May 12, 2023

SELL
$2.77 - $5.49 $13,850 - $27,450
-5,000 Reduced 10.54%
42,427 $118,000
Q2 2022

Aug 10, 2022

BUY
$3.8 - $6.08 $180,222 - $288,356
47,427 New
47,427 $183,000

Others Institutions Holding IPA

About ImmunoPrecise Antibodies Ltd.


  • Ticker IPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,836,700
  • Market Cap $8.44M
  • Description
  • ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...
More about IPA
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.